Another bluebird exec jumps ship as questions swirl over gene therapies and imminent split
On the same day that their former COO found a new job steering the ship at a biotech focused on engineering B cells, bluebird …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
